evolcSign inStart free
Menu

Abivax

Develops obefazimod and other therapeutics for patients with chronic inflammatory diseases

Paris, FranceFounded 2013abivax.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-30

About Abivax

Abivax is a clinical-stage biotechnology company developing therapeutics that harness natural regulatory mechanisms to stabilize the immune response. Its lead candidate, obefazimod, is an investigational oral small molecule that enhances miR-124 expression.

The company aims to develop and commercialize obefazimod, initially for ulcerative colitis, and is studying it for Crohn’s disease and other inflammatory indications. It is also investigating follow-on compounds and maintains a proprietary chemical library.

Founded in 2013, Abivax is headquartered in Paris, France.

Product: Clinical development of obefazimod and follow-on compounds for inflammatory diseases.

Jobs at Abivax

No open positions listed right now.

Leadership

  • Marc de Garidel · Chief Executive Officer
    Source: company website
  • Didier Blondel · Executive Vice President, Chief Financial Officer and Board Secretary
    Source: company website
  • Ida Hatoum · Chief People Officer, Chief Compliance Officer
    Source: company website
  • Michael Nesrallah · Chief Commercial Officer
    Source: company website
  • Tim Kelly · Chief Technical Officer
    Source: company website
  • Kevin Shan · Vice President, Global Head of Biometrics
    Source: company website
  • Nadège Briancon-Eris · Senior Vice President, Global Head of Development Operations
    Source: company website

More biotech & pharma companies

  • Acticor Biotech

    Clinical-stage biopharma developing glenzocimab, an antithrombotic antibody fragment for acute ischemic stroke patients
    Paris, FranceBiotech & pharmaFounded 20131 open job
    New on Evolc

  • Ademtech

    Magnetic particles and molecular diagnostic kits for IVD, life sciences and forensic laboratories
    Merignac, FranceBiotech & pharmaFounded 2000
    New on Evolc

  • Adocia

    Develops clinical-stage treatments for diabetes and obesity for patients with metabolic diseases
    Lyon, FranceBiotech & pharmaFounded 2006
    New on Evolc

  • Adragos Pharma

    Contract development and manufacturing for pharma and biotech clients in Europe, Japan and North America
    FranceBiotech & pharma31 open jobs

  • Advesya

    Clinical-stage biotech developing IL-1RAP-targeted CAR T-cell and ADC treatments for cancer and autoimmune diseases
    Paris, FranceBiotech & pharmaFounded 2020
    New on Evolc

  • Aelis Farma

    Develops CB1-targeted drug candidates for people with cannabis-related disorders and cognitive deficits
    Pessac, FranceBiotech & pharmaFounded 2013
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cloudflare
  • Fastly
  • Google Tag Manager
  • Google Universal Analytics
  • New Relic
  • Termly
  • WordPress
  • jQuery